Dr Martens has reported a 10 per cent revenue drop to $1.071 billion for FY25 in its preliminary results, with adjusted profit before tax falling to $46.4 million.
Despite the decline, it met key goals including DTC growth in the Americas, $34 million in cost savings, and a stronger balance sheet.
Its new strategy, Levers For Growth, targets profit recovery in FY26.